SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-025947
Filing Date
2016-07-29
Accepted
2016-07-29 16:50:43
Documents
1
Period of Report
2016-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3380
  Complete submission text file 0000899243-16-025947.txt   4808
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES HEALTH, INC. 161 FIRST STREET CAMBRIDGE MA 02472
Business Address
Aunins John G. (Reporting) CIK: 0001643756 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 161794661